Neuroscience letters · 2008
Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matter.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Boccardi Marina, Scassellati Catia, Ghidoni Roberta, Testa Cristina, Benussi Luisa, Bonetti Matteo, Bocchio-Chiavetto Luisella, Gennarelli Massimo, Binetti Giuliano, Frisoni Giovanni B
Аннотация
The frequent polymorphism XbaI (A351G) in the estrogen receptor alpha (ERalpha) gene has been associated with some postmenopausal pathologies' risk such as Alzheimer's disease (AD) or cognitive decline. In the present study, we explored whether the XbaI polymorphism leads to different gray matter volumes using voxel-based morphometry (VBM) on 20 magnetic resonance images of healthy postmenopausal women. Subjects carrying the less common XbaI/X allele were contrasted to non-carriers in groups well balanced by relevant confounding variables. The XbaI/X allele carriers displayed clusters ranging from 9 to 28% of tissue reductions in the cerebellar (cluster size, z, stereotactic coordinates: 16 mm(3); 3.17; 14, -94, -38) and cerebral cortex, in particular in the occipital lobe (272 mm(3); 3.76; -38,-68,-16), in the middle frontal gyrus (192 mm(3); 3.71; 38, 12, 38) and in the middle temporal gyrus, while the opposite comparison was negative. The XbaI/X allele in ERalpha gene is associated to smaller gray matter volumes of the cerebral and cerebellar cortex. This allele might increase the susceptibility for senile neurodegenerative conditions, being associated to smaller cerebral reserve.
Предметные рубрики MeSH
Alzheimer DiseaseAtrophyBrainCognition DisordersCytoprotectionDNA Mutational AnalysisDementiaDeoxyribonucleases, Type II Site-SpecificDisease ProgressionEstrogen Receptor alphaEstrogensFemaleGene FrequencyGenetic Predisposition to DiseaseGenetic TestingGenotypeHeterozygoteHumansMagnetic Resonance ImagingMiddle AgedPolymorphism, GeneticPolymorphism, Restriction Fragment LengthPostmenopause